FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

21,238 resources

Type: Text:

By Version

R2: 0
R2B: 0
R3: 568
R4: 19,738
R4B: 121
R5: 810
R6: 1

By Authority

none: 2,000
hl7: 19,236
national: 2

Start Prev Rows 7800 - 8000 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1070.json	Urinary incontinence I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1071.json	Urinary incontinence	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1073.json	Hemifacial spasm SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1074.json	Hemifacial spasm I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1075.json	Hemifacial spasm	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1076.json	Spasmodic dysphonia SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1077.json	Physical therapy procedure SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1078.json	Occupational therapy SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1079.json	Hyperhidrosis SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1080.json	Hyperhidrosis I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1081.json	Hyperhidrosis	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1082.json	Tic disorder I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1083.json	Tic disorder SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1084.json	Tic disorder	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1085.json	Esophageal achalasia SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1086.json	Esophageal achalasia I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1087.json	Esophageal achalasia	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1088.json	ET propanolol or primidone	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1089.json	ET topiramate alprazolam or gabapentin	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.109.json	CKD stage4above I10	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1090.json	Blephraospasm SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1091.json	Blepharospasm I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1092.json	Blepharospasm	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1093.json	Strabismus SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1094.json	Strabismus I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1095.json	Strabismus	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1096.json	Overactive bladder SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1097.json	Overactive bladder I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1098.json	Overactive bladder	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1099.json	Movement disorders SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.110.json	CKD stage4above SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1100.json	Movement disorders I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1101.json	Movement disorders	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1102.json	Lateral epicondylitis SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1103.json	Lateral epicondyltisis I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1104.json	Lateral epicondylitis	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1105.json	Plantar fasciitis SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1106.json	Plantar fasciitis I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1107.json	Plantar fasciitits	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1108.json	Cardiac CT SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1109.json	Cardiac CT CPT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.111.json	CKD stage4above	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1111.json	Cardiac CT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1112.json	Cardiac MRI SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1113.json	Cardiac MRI CPT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1114.json	Cardiac MRI	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1115.json	CT Angiography of Coronary Artery SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1116.json	CT Angiography of Coronary Artery CPT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1117.json	CT Angiography of Coronary Artery	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.120.json	Diabetic ketoacidosis SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.121.json	Diabetic ketoacidosis	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.146.json	Long Acting Muscarinic Antagonists (LAMA)	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.159.json	conditions_COPD I10	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.175.json	Asthma	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.184.json	DigTx Virtual Reality Contraindications Visual Impairment	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.186.json	Beta blockers GDMT for heart failure	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.188.json	medications_heart failure	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.197.json	Blood (Serum and Plasma) Potassium	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.214.json	Type 1 Diabetes Mellitus SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.238.json	MRA mineralocorticoid receptor antagonists	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.244.json	MRA Mineralocorticoid Receptor Antagonist Allergy	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.260.json	UACR SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.263.json	Pregnancy I10	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.281.json	Statins Allergy SCT	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.282.json	Statin Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.314.json	relatedconditions_hyperlipidemia I10	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.337.json	Migraine I10	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.34.json	Blood pressure panel	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.35.json	Systolic Blood Pressure	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.367.json	Trandolapril	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.369.json	Candesartan	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.377.json	Valsartan	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.397.json	eGFR	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.412.json	Statin Moderate Intensity	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.415.json	LDL Cholesterol	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.43.json	Urinalysis	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.434.json	Insulin	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.437.json	TZD Thiazolidinediones	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.438.json	medications_T2DM	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.440.json	relatedconditions_T2DM SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.442.json	Blood Glucose	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.459.json	Liver cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.47.json	ACE inhibitor allergy SCT	active	2022-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.474.json	Allergy to Tdap Vaccine	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.475.json	Allergy to Td Vaccine	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.481.json	medications_hypertension	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.492.json	Inhaled Corticosteroids Allergy	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.498.json	Metformin AllergyIntolerance SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.508.json	Abdominal aortic imaging CPT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.517.json	Hemoglobin A1c	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.518.json	Drug hypersensitivity I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.519.json	Drug hypersensitivity SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.520.json	Drug hypersensitivity	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.521.json	Diabetic Kidney Disease I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.523.json	Diabetic kidney disease	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.524.json	Chronic Hepatitis SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.525.json	Chronic Hepatitis	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.527.json	OCS_Prednisone	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.531.json	Anti IgE Medications	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.532.json	IL5 Antagonists	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.533.json	Mast cell stabilizers for asthma	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.534.json	Vasospastic disease I10	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.535.json	Vasospastic disease SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.536.json	Vasospastic disease	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.537.json	Hemiplegic and basilar migraine I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.538.json	Hemiplegic and basilar migraine SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.539.json	Hemiplegic and basilar migraine	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.540.json	Peptic ulcer disease I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.541.json	Peptic ulcer disease SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.542.json	Peptic ulcer disease	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.544.json	Bleeding disorder I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.545.json	Bleeding disorder SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.548.json	Electronic cigarettes or Vaping	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.549.json	Bleeding disorder	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.552.json	Triptans	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.553.json	CGRP receptor antagonists	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.554.json	Ditans	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.555.json	Ergots	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.556.json	Migraine specific NSAIDs	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.557.json	OTC migraine analgesics	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.559.json	medications_migraine_acute	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.560.json	relatedconditions_migraine I10	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.561.json	conditions_migraine	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.562.json	relatedconditions_migraine SCT	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.563.json	relatedconditions_migraine	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.564.json	Triptan Allergy Intolerance SCT	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.565.json	Triptan Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.566.json	Ischemic bowel disease SCT	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.567.json	Ischemic bowel disease I10	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.568.json	Ischemic bowel disease	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.573.json	conditions_hyperlipidemia I10	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.574.json	conditions_hyperlipidemia SCT	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.575.json	conditions_hyperlipidemia	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.578.json	PIM_Schedule V	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.580.json	PIM_Acarbose	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.582.json	PIM_Dulaglutide	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.583.json	PIM_Glimepiride	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.585.json	PIM_Glucophage	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.587.json	PIM_Glucovance	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.588.json	Glyburide PIM	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.590.json	Alpha glucosidase inhibitors	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.592.json	Azotemia	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.594.json	Intolerance to ARB SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.595.json	ICS Low	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.596.json	ICS Medium	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.597.json	ICS High	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.598.json	Low Dose ICS Formoterol	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.600.json	PIM_Vitamin B12 Level_LOINC	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.601.json	PIM_Vitamin B12 Level_CPT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.604.json	PIM_Glyburide	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.605.json	PIM_Pioglitazone	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.606.json	PIM_Semaglutide	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.607.json	PIM_Linagliptin	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.609.json	Macrolide_Azithromycin	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.61.json	Secondary antihypertensives	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.610.json	Long Acting Beta Agonists (LABA) Non_Formoterol	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.612.json	Wolff Parkinson White SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.613.json	Wolff Parkinson White I10	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.614.json	Wolff Parkinson White	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.615.json	medications_Asthma	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.619.json	ICS_LABA_LAMA	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.620.json	Low Dose ICS_LABA_Non Formoterol	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.621.json	Medium ICS_LABA Non Formoterol	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.623.json	LAMA Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.624.json	LABA Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.625.json	BetaBlock NonCS Secondary Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.626.json	Eplerenone Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.627.json	Spironolactone Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.628.json	SGLT2 Inhibitors Allergy SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.629.json	PIM_Refill_Request_Antilipemics_LFTs	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.630.json	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.631.json	Pneumococcal Vaccine Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.632.json	Meglitinides Allergy SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.633.json	DPP4i Allergy SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.635.json	Alpha_glucosidase inhibitors allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.636.json	Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.637.json	Insulins Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.638.json	TZD Allergy SCT	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.639.json	T2DM_Medications Allergy SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.642.json	T2DM_Medications Allergy RXNORM	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.643.json	T2DM_Medications Allergy SNOMED	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.646.json	T2DM_Medication Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.647.json	Statins Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.649.json	ACE Inhibitors Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.650.json	ARB Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.652.json	Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.653.json	Long Acting Beta Agonists (LABA) Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.654.json	BetaBlocker NonCS Secondary Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.656.json	MRA Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.657.json	Eplerenone Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.658.json	Spironolactone Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.659.json	SGLT2i Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.660.json	Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.661.json	Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.665.json	Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.666.json	Human Papillomavirus (HPV) vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.667.json	Herpes Zoster Vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.670.json	Pneumococcal Vaccine Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.671.json	Inhaled Corticosteroids(ICS) Allergy Intolerance	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.672.json	LABA(Formoterol only)	active	2023-11	hl7